CPIN:IDXPT Charoen Pokphand Indonesia Tbk Analysis

CPIN is trading at €12.28, comfortably above its 30‑day support of €12.20 but still 9% below the 52‑week high of €14.04. The 20‑day SMA (13.04) sits above the 50‑day (12.57) and 200‑day (12.16) averages, indicating a short‑term bullish bias. However, the MACD histogram remains negative and the MACD signal is flagged “bearish,” suggesting lingering downside momentum. RSI at 40.4 points to a neutral‑to‑slightly‑oversold condition, leaving room for a modest rebound. Volume has been increasing, supporting the price’s resilience near support.
Fundamentally, the stock appears undervalued with a trailing P/E of 11.7 versus an industry average of 32.5 and a price‑to‑book of 0.74. The dividend yield of 16.2% is exceptionally high, but a payout ratio of 94% coupled with zero operating cash flow raises sustainability concerns. Leverage is elevated, with a debt‑to‑equity of 96, though the beta of 0.15 signals low market sensitivity. The REIT’s exposure across Belgium, the Netherlands, Spain and Ireland spreads geographic risk, while the healthcare‑facility focus offers defensive demand. Given the mixed technical signals, attractive valuation and dividend upside, we recommend a “hold” stance in the short term, a “buy” for medium‑term income seekers, and a cautious “hold” for long‑term investors wary of cash‑flow constraints.